SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-23-017970
Filing Date
2023-05-17
Accepted
2023-05-17 17:02:28
Documents
16
Period of Report
2023-05-12
Items
Item 4.01: Changes in Registrant's Certifying Accountant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 42056
2 ex16-1.htm EX-16.1 5599
3 ex16-1_001.jpg GRAPHIC 32161
4 ex16-1_002.jpg GRAPHIC 3843
5 ex16-1_003.jpg GRAPHIC 69052
  Complete submission text file 0001493152-23-017970.txt   363594

Data Files

Seq Description Document Type Size
6 INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT vicp-20230512.xsd EX-101.SCH 3227
7 INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT vicp-20230512_lab.xml EX-101.LAB 34240
8 INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT vicp-20230512_pre.xml EX-101.PRE 22359
10 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3290
Mailing Address 1735 BUFORD HIGHWAY STE. 215-113 CUMMING GA 30041
Business Address 1735 BUFORD HIGHWAY STE. 215-113 CUMMING GA 30041 470-514-4013
Vicapsys Life Sciences, Inc. (Filer) CIK: 0001468639 (see all company filings)

IRS No.: 621153426 | State of Incorp.: FL | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-56145 | Film No.: 23932640
SIC: 2834 Pharmaceutical Preparations